Carregant...

Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery

BACKGROUND: The majority of patients with acute myelogenous leukemia (AML) still die of their disease. In order to improve survival rates in AML patients, new strategies are necessary to discover biomarkers for the detection and targeted therapy of AML. One of the advantages of the aptamer-based tec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, Mingli, Jiang, Guohua, Li, Wenjing, Qiu, Kai, Zhang, Min, Carter, Christopher M, Al-Quran, Samer Z, Li, Ying
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3895837/
https://ncbi.nlm.nih.gov/pubmed/24405684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-7-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!